Denis Poddubnyy

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer et al. · Annals of the Rheumatic Diseases · 2020 · 917 citations · Full text

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano et al. · Annals of the Rheumatic Diseases · 2022 · 808 citations · Full text

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

Josef S Smolen, Monika Schöls, Jürgen Braun et al. · Annals of the Rheumatic Diseases · 2017 · 662 citations · Full text

Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis

Denis Poddubnyy, Hildrun Haibel, Joachim Listing et al. · Arthritis & Rheumatism · 2011 · 463 citations

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 349 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +14